À propos de Pharmacolog

Pharmacolog SARL fournit des solutions et des produits qui améliorent l’efficacité et la sécurité au travail lors de la préparation de traitements injectables. Notre objectif est d’aider à prévenir les erreurs liées aux médicaments et d’assurer l’efficacité maximale des traitements pour les patients traités avec des médicaments injectables puissants mais potentiellement nocifs.

Nos produits, DrugLog®, WasteLog™ et PrepLog®, aident le personnel des pharmacies et des services de soins hospitaliers à minimiser le risque d’erreurs durant le processus d’élaboration des préparations. De plus, nos solutions jouent également un rôle essentiel dans la lutte contre l’usage détourné des médicaments, en permettant de vérifier que les médicaments et les stupéfiants utilisés en chirurgie n’ont pas été employés à mauvais escient.

Notre vision
Un système de santé avec une approche individuelle centrée sur le patient où tous les paramètres disponibles sont pris en compte dans la sélection et l’administration des médicaments, et où les médicaments sont contrôlés et ajustés tout au long du traitement en fonction de l’état et de la réponse du patient.

Notre mission
Fournir des solutions et des produits dans le cadre de l’administration et de la délivrance des médicaments pour délivrer un traitement individuel et optimisé pour chaque patient.


Uppsala, Mars 2017

 

Dear all,

Modern medicine has never had such extensive collection of drugs and substances to choose from in the aim to provide the best possible care to patients. Although high level of innovations within the pharma industry, many of the protocols and instructions that guide healthcare personnel when determining correct concentration for a specific medication are based on old, outdated studies. Also, despite using highly sophisticated substances, the efficacy of the complete treatment also depends on how the drug is administered to the patient. During an infusion of a drug, the intention is to administer the drug to the patient with a same concentration throughout the complete infusion, [ska detta vara med: but what if the drug is unequally distributed in the infusion container? The patient might receive very high concentrations temporarily, something that can lead to damaging effects and reduce the efficacy of the treatment].

Pharmacolog’s mission is to provide solutions and products within the drug administration and the drug delivery process for accurate and individually optimized patient treatment.

A first step towards achieving that mission, is to help ensure that the compounded medication contains correct drug with the right concentration. This can now easily be accomplished with our DrugLog® system. DrugLog® is the first link in the subsequent development of new methods and procedures for ensure optimal handling of intravenous medicines. Pharmacolog aim to become the market leader in tools for ensuring medication efficacy in personalized medicine.

Advanced tools for intravenous drug administration, treatments and quality control are being developed in close co-operation with research institutes and medical clinics world-wide.

I am very proud and happy to be part of a talented team operating in such an important and exciting area. To be a part of improving healthcare throughout the world and work towards truly personalized medicine.

Mats Högberg
CEO of Pharmacolog AB (publ.)

Why Pharmacolog?

After 40 years in clinical work, research and companies focused on developing methods and solutions for better cancer care with radiotherapy, I realized in early 2000 that to achieve an overall better and more individualized treatment of cancer, other disciplines like chemotherapy has to be improved. Research showed considerable lack of accuracy and safety when treating patients with intravenous drugs, which very often also resulted in serious mistreatments, patient suffering and substantial costs for the society.

Several technical innovations and clinical tests made it possible to establish the company Pharmacolog in 2007 together with the now deceased Kjell Westerlund, an icon in developing QA tools for radiotherapy.

The business idea for Pharmacolog was to develop a product based on spectroscopic technology for securing treatments with cytostatic drugs to ensure that the right drug, with the right concentration, is given at the right time and to the right patient.

It has been a fantastic journey together with competent and engaged team of experts over the last five years. Now Pharmacolog can present a stable and user-friendly product to the market. DrugLog® can play an important role in preventing mistreatments and patient sufferings, which directly improve the quality of life for patients, and decreases healthcare costs.

Pharmacolog’s long-term goal is to continue the mission to develop tools and methods together with research centers, MedTech and Drug companies, to make personalized  treatment possible.

Hans Dahlin
Founder of Pharmacolog AB (publ.)

After working in clinical research and establishment of different companies in the 80th and 90th for safe and accurate treatment of cancer with Radiation Therapy, the recognition in early 2000 of the huge lack of control methods when treating patients with intravenous drugs like cytotoxics was chocking for me. After some early tests of different spectroscopic technologies for analysing liquid drugs, Pharmacolog was established in 2007 with the mission still valid. (Hans Dahlin, Founder, Pharmacolog AB)

Subscribe

Get notified when a new press release, blog article or event is posted on our website!

Select list(s)*

Loading

 

Read our Privacy policy (Swedish).